TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 139 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2017. The put-call ratio across all filers is 6.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $492,000 | -85.1% | 4,251 | -86.5% | 0.01% | -79.5% |
| Q4 2017 | $3,296,000 | +847.1% | 31,473 | +955.4% | 0.04% | +1000.0% |
| Q1 2017 | $348,000 | -32.8% | 2,982 | -16.2% | 0.00% | -33.3% |
| Q2 2016 | $518,000 | +4.0% | 3,558 | +10.4% | 0.01% | -53.8% |
| Q4 2015 | $498,000 | – | 3,224 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 1,104,168 | $154,849,000 | 80.27% |
| Consonance Capital Management LP | 378,372 | $53,063,000 | 7.89% |
| Moab Capital Partners | 93,133 | $13,061,000 | 6.27% |
| Greywolf Capital Management LP | 277,936 | $38,978,000 | 5.77% |
| Perceptive Advisors | 301,333 | $42,260,000 | 4.15% |
| Valentine Capital Asset Management, Inc. | 141,270 | $19,812,000 | 3.81% |
| Raging Capital Management, LLC | 253,236 | $35,514,000 | 3.78% |
| Ativo Capital Management LLC | 18,058 | $2,532,000 | 1.10% |
| Geduld E E | 8,000 | $1,122,000 | 0.70% |
| Assured Investment Management LLC | 192,389 | $26,981,000 | 0.46% |